ArticleIJTLD open2026
The impact and cost of using mobile digital X-ray units to detect pulmonary TB in South Africa.
Article in IJTLD open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundDigital chest X-ray (dCXR) enables early TB detection where symptoms screening is inadequate. We evaluated the impact and cost of three dCXR delivery models: long-term community-based mobile vans (LT-vans), long-term facility-based containers (LT-containers), and short-term community-based mobile vans (ST-vans), implemented by a non-governmental organisation (NGO) across two South African provinces.
methodsBetween 2020 and 2022, nine dCXR units were deployed in four high-TB-burden districts for 1-19 months. Screening yield and TB test positivity were collected from electronic databases. Costs were estimated from the provider perspective using micro-costing methods, with both economic and financial costs reported for NGO-led and routine care implementation.
resultsOverall, 34,110 individuals were screened, 8,605 (25.2%) had abnormal dCXR results, and 1,372 TB cases were diagnosed (4.0% positivity). The cost per person screened with dCXR ranged from $39 to $240. LT-vans had the highest TB positivity (10.1%), followed by LT-containers (3.7%) and ST-vans (1.7%). The lowest cost per TB case identified was with LT-vans ($384 economic; $375 financial) under routine care implementation, and the highest with ST-vans ($14,157 economic; $8,741 financial) under NGO-led implementation.
conclusionLong-term mobile vans were the most cost-effective model, yielding the highest TB rates, while short-term vans offered high volumes but at higher costs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.